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Objective: To evaluate the role of preradiosurgical embolization on obliteration rate, 
reduction of size, irradiation dose, and neurological outcome, in 90 patients presenting 
large arteriovenous malformations (AVMs).
Methods: Between October 1993 and October 2006, 90 radiosurgical procedures 
were performed to treat brain AVMs Spetzler–Martin (SM) grades III, IV, and V at the 
Department of Radiosurgery and Radiology of the Real e Benemérita Associação 
Portuguesa de Beneficência de São Paulo, São Paulo, Brazil. Fifty-nine patients had 
embolization before radiosurgery and complete clinical and radiologic follow-up for at 
least 3 years. Inclusion criteria were as follow: SM grades III, IV, and V AVMs, no previ-
ous treatment, and clinical and radiological (angiogram and MRI) follow-up for at least 
3 years. Obliteration rate, reduction of size, irradiation dose, and neurological outcome 
were compared in these two cohorts of patients. Mann–Whitney test, “Student’s t-test,” 
and χ2 tests were used for statistical analysis, as appropriate. The level of significance 
was determined at p < 0.05.
results: The mean size of the AVMs that underwent embolization was significantly 
greater when compared with non-embolized group (p < 0.05). Embolization significantly 
reduced the AVM diameter. Irradiation dose was significantly smaller in the embolized 
group (p <  0.05). No significant differences in final clinical outcomes, postprocedural 
radiological findings, rate of occlusion, and need for additional procedures were observed 
between the two groups (p < 0.05).
conclusion: Preradiosurgical embolization of large AVMs does not result in impaired 
obliteration rate compared with cases treated with radiosurgery alone. It did not add 
further morbidity and presented benefits of reducing size of the AVMs. Preradiosurgical 
embolization may facilitate the coverage of the AVM with the effective irradiation 
dose. Combined management may be effective for selected large lesions considered 
unsuitable for radiosurgery and otherwise untreatable.
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inTrODUcTiOn
Intracranial arteriovenous malformations (AVMs) constitute a 
formidable medical challenge. When amenable, surgical treat-
ment is the best option because it affords immediate cure and 
prevents hemorrhage. However, surgery is not always feasible 
and frequently additional therapeutic modalities, such as embo-
lization and radiotherapy, are required. Radiosurgery may be 
employed as an alternative to microsurgery in small lesions or as 
a part of a combined treatment of Spetzler–Martin (SM) grades 
III, IV, and V AVMs. However, it does not always obliterate the 
nidus completely (1–21). The occlusion rate varies proportionally 
with the inverse of the AVM’s diameter. Therefore, large AVMs 
are not suitable for radiosurgical treatment unless their size is 
reduced.
In thesis, initial volume reduction with endovascular embo-
lization is useful in large AVMs and may facilitate complete 
obliteration with therapeutically effective dose. However, the 
role of preradiosurgical embolization is still to be definitively 
established. Most of the reports actually indicate that it reduces 
the obliteration rate and increases morbidity (2, 6, 14, 22), and 
many authors indeed do not recommend preradiosurgical embo-
lization. Therefore, a large number of patients are left untreated.
In this paper, we retrospectively investigated 90 patients pre-
senting III, IV, and V SM grade AVMs, treated with or without 
preradiosurgical embolization between 1993 and 2006, aiming to 
evaluate the role of this procedure on obliteration rate, reduction 
of size, need for additional procedures, irradiation dose, and 
neurological outcome.
MaTerials anD MeThODs
Between October 1993 and October 2006, 90 radiosurgical 
procedures were performed to treat brain AVMs SM grades III, 
IV, and V, at the Department of Radiosurgery and Radiology of 
the Real e Benemérita Associação Portuguesa de Beneficência de 
São Paulo, São Paulo, Brazil. A multidisciplinary team consist-
ing of vascular neurosurgeons, endovascular therapists, and 
radiosurgeons initially was involved in this study. Of these 90 
patients, 59 had embolization before radiosurgery and complete 
clinical and radiologic follow-up for at least 3 years. AVMs were 
classified according to the SM grading system by neurosurgeons, 
interventional radiologists, and radiosurgeons.
Forty-six (51.1%) patients were female and 44 (48.9%) were 
male. Mean age was 30.6 years. Asymptomatic AVMs are com-
posed of 7.8% (seven cases). Inclusion criteria were SM grades III, 
IV, and V AVMs, AVMs with no previous treatment, and patients 
with clinical and radiological (angiogram and MRI) follow-up for 
at least 3 years. From the original cohort of 105 patients, 15 did 
not meet the inclusion criteria.
Clinical presentation is detailed in Table 1. Forty-one (45.6%) 
patients presented with hemorrhage (Table 2). Fifty-two patients 
(57.8%) presented angioarchitectural abnormalities, including 
intranidal aneurysms, arterial or venous stenosis, and venous 
ectasia. Occlusion rate, irradiation doses, clinical morbidity, 
and radiological complications were evaluated and compared 
between the two groups.
endovascular Procedure
The goals of the procedure were to decrease the size of lesion 
and target lesions that would increase the risks for hemorrhage, 
such as aneurysms. All procedures were carried out under gen-
eral anesthesia. A 5- or 6-French guide catheter was introduced 
in the femoral artery and placed in the internal carotid or 
vertebral artery.
Angiography was then performed, followed by superselec-
tive catheterization of the AVM feeders, using an Ultraflow 
HPC™ microcateter (1.5  Fr) (Micro Therapeutics, Inc., Irvine, 
CA, USA), which allowed a better understanding of the AVM 
angioarchitectural findings. Intranidal catheter position was 
achieved whenever it was feasible. Lipiodol and Histoacryl 
(Braun Melsugen SA, S. Gonçalo, RJ, Brazil) were used as agents 
of embolization. No more than one-third of the lesion was 
embolized per  session. Every effort was made to target feeders 
harboring intranidal aneurysms. In cases that need additional 
sessions, the interval between them was at least 30 days. Dynamic 
subtraction fluoroscopy was employed to display the nidus and 
feeders, as well as the cast.
radiosurgery
The planning was done using Brain Scan, Image Fusion 5.3.1 
(BrainLab, Munich, Germany) based on the combination of 
the angiographic data, contrast-enhanced CT images, and 
thin-sliced MRI. The selection of the radiation dose dependent 
on location and target volume. The maximal dose varied from 
1200 to 2500 cGy, at an isodose of 80%. No difficulties related 
to the previous partial embolization of the lesion were observed. 
Radiation was delivered using Varian 6 MV system (Varian, Inc., 
Palo Alto, CA, USA).
Follow-up
Patients were followed up with clinical examinations for at least 
3 years after treatment. Clinical follow-up was carried out in the 
3rd, 6th, and 12th months, and once per year thereafter. MRI was 
TaBle 5 | Transient clinical complications in the embolized group.
clinical complications n %
Hemiparesis 5 8.4
Seizures 1 1.6
Wallenberg syndrome 1 1.6
TaBle 4 | Permanent clinical complications in the embolized group.
clinical complications n %
Hemiparesis 4 6.7
Hemiparesis + disfasia 1 1.6
Hemifacial anesthesia + diplopia + vertigo 1 1.6
Hemiparesis + disartria + cerebellar syndrome 1 1.6
Deafness 1 1.6
TaBle 3 | Volume before rDs and irradiation does in the two groups.
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used to follow the patients once per year. Cerebral angiography 
was performed 3 years after treatment.
statistical analysis
Mann–Whitney test, “Student’s t-test,” and χ2 tests were used for 
statistical analysis, as appropriate. The level of significance was 
determined at p < 0.05.
resUlTs
Arteriovenous malformations were located in the frontal lobe 
(n  =  18; 20%), parietal lobe (n  =  15; 16.7%), basal ganglia 
(n = 15; 16.7%), thalamus (n = 12; 13.3%), temporal lobe (n = 7; 
7.8%), ventricles (n = 7; 7.8%), occipital lobe (n = 6; 6.7%), insula 
(n = 5; 5.6%), cerebellum (n = 4; 4.4%), and corpus callosum 
(n = 1; 1.1%).
Table  1 summarizes the clinical data. Motor deficit was 
presented in 41 patients (45.6%), whereas asymptomatic cases 
were composed of 7.8% (n =  7). Forty-nine patients (60%) 
presented grade III AVMs. Embolization significantly reduced 
the AVM diameter and AVM’s grade. Embolized AVMs pre-
sented greater volume than non-embolized ones (p = 0.013). 
Irradiation dose was significantly smaller in the embolized 
group (p = 0.029) (Table 3).
Permanent complications occurred in eight (13.5%) patients 
in the embolization group (Table  4). Two motor deficits were 
related to bleeding. Ischemic events occurred in six patients. 
Transient clinical complications occurred in seven patients 
(11.7%) in the embolized group (Table  5). Complications in 
the non-embolized group were related with biological effects of 
radiation and were managed using corticoids. Delayed radiation 
induced a permanent complication in one patient. Two patients 
experienced hemorrhage during the latency period without 
related neurological deficits. Additional radiosurgical procedure 
was performed in 7 (22.6%) in the non-embolized group and in 
25 patients (42.4%) of the embolized group.
No significant differences in final morbidity, postprocedural 
radiological findings, rate of occlusion, and need for additional 
procedures were observed between the two groups.
DiscUssiOn
Grades I and II AVMs may be effectively treated either by sur-
gery or radiosurgery; however, management of larger lesions 
represents a formidable challenge and most often requires 
multiple treatment strategies (5, 14, 20, 23, 24). In this setting, 
initial endovascular embolization, aiming to decrease AVM’s size, 
combined with stereotactic radiosurgery represents an empirical 
option. Nonetheless, the benefits and advantages of preradiosur-
gical embolization have not been defined thus far (2, 3, 9, 11, 24). 
Indeed, the drawbacks of preradiosurgical embolization have 
been often emphasized (2, 3, 9, 11, 20).
In several studies, preradiosurgical nidus embolization was 
associated with lower obliteration rate, higher morbidity, and 
worse outcomes (18). Andrade-Souza et  al. (25) demonstrated 
that obliteration occurred in 47% of patients treated with embo-
lization compared with 70% of the radiosurgery-alone group. 
Schlienger et  al. (18) verified that the obliteration rate reaches 
54% in cases with preradiosurgical embolization and 71% in 
radiosurgery-alone cohort. Other study showed obliteration rates 
of 26 and 76% for embolized and non-embolized lesions, respec-
tively (15). Pollock et al. found that preradiosurgical embolization 
was considered as a negative factor for obliteration and optimal 
results (26). Xu et al. meta-analyzed 10 studies that demonstrated 
no benefits for preradiosurgical embolization; however, there 
were significant publication bias (27).
Various factors have been considered as responsible for such 
unsatisfactory outcomes. Indeed, ineffective embolization with-
out reduction of AVM’s total volume may difficult radiosurgical 
targeting (6, 11, 22). Moreover, partial embolization may cause 
dissociation of the AVM into distinct compartments, impairing 
conformal radiosurgical planning (6, 11, 18, 21).
Conversely, other studies have shown different conclusions. 
Izawa et al. (11) reported that preradiosurgical embolization did 
not result in improved occlusion or higher complications rates. 
Indeed, it may facilitate complete coverage with effective dose. 
Blackburn et al. (2) conclude that staged preradiosurgical endo-
vascular embolization provides an effective means of treating 
large AVMs not amenable to surgical or radiosurgical-alone treat-
ments. The outcomes and complication rates compare favorably 
to the results of other reported therapeutic strategies (2).
In this study, the obliteration rate and long-term morbidity 
after combined management of AVMs with embolization and 
FigUre 1 | a 37-year-old female presents with a grade iV frontal lobe aVM. (a) RMI depicts a right frontal lobe AVM. (B) Anteroposterior angiogram view.  
(c) Anteroposterior angiogram view after embolization displays a significant reduction of the AVM’s size. Anteroposterior (D) and lateral (e) angiogram views 
conveying total obliteration of the AVM 2 years radiosurgery (1700 cGy).
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radiosurgery do not significantly differ. The greater mean nidus 
volume in the embolization group may imply that embolization 
was mainly indicated in larger lesions, and therefore, it can be 
speculated that reduction of the nidus’ size might play an impor-
tant role in the overall effectiveness of treatment. Large AVMs 
were converted to smaller ones, feasible to radiosurgery and 
otherwise untreatable lesions (Figures 1 and 2).
Notwithstanding, combined management may result in 
associating the intrinsic morbidity of both procedures (11). 
Nonetheless, no major neurologic deterioration was observed 
after embolization, probably reflecting careful case selection and 
non-aggressive strategy of endovascular management. Aggressive 
embolization of a large AVM in a single session may augment the 
risks (5, 11, 22, 23, 25, 28).
The reported rate of long-term postradiosurgical complica-
tions in previously embolized cases was higher, equal (9, 11), 
or lower (2, 13) than in cases treated with radiosurgery alone 
(11). In our study, the long-term morbidity rate did not differ 
significantly between the groups with and without previous 
embolization.
A substantial benefit of preradiosurgical embolization was 
the overall reduction of the irradiation dose, even considering 
the additional radiation dose required in further radiosurgical 
procedures. Significant reduction of size was probably respon-
sible for the complete coverage of the nidus with the effective 
dose. Even though, the occlusion rates did not differ significantly, 
several lesions that could be left untreated were effectively man-
aged and occluded.
limitations of the study
This is a retrospective study, and as such, it is susceptible to sys-
tematic errors (bias). In the embolized group, AVMs were larger 
than in radiosurgery-only group, which may introduce selection 
bias, even though, there were no statistical differences between 
the two groups. A subgroup analysis has not been performed, for 
small or large AVMs, due the insufficient number of cases, which 
may underpower the study.
In this series, mean patient age was 30.6 years. The follow-up 
period of 3 years is relatively short and may be difficult to make 
definitive recommendations for this particular group, as younger 
patients have higher chance of rebleed in the long term, after 
non-surgical treatment.
We found no statistical differences regarding percentage of 
occlusion and need for further procedures, results that are dif-
ferent from other studies and which may represent an additional 
contribution to the literature in this controversial matter.
FigUre 2 | a 21-year-old male with a parietal lobe hemorrhage. Angiogram diagnosed a grade IV AVM. (a) Anteroposterior view. (B) Lateral view. Four years 
after radiosurgery (2200 cGy) angiogram evidenced total occlusion. (c) Anteroposterior view. (D) Lateral view.
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cOnclUsiOn
This study has demonstrated that partial embolization of intrac-
ranial AVMs before stereotactic radiosurgery does not result in 
statistically significant impaired obliteration rate compared with 
cases treated with radiosurgery alone. Preradiosurgical emboliza-
tion may present benefits of reducing size of the AVMs and may 
facilitate the coverage of the AVM with the effective irradiation 
dose. Thus, combined management may be effective for selected 
and otherwise deemed untreatable cases.
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